世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
腫瘍液生検の世界市場レポート、歴史と予測2018-2029年、企業別、主要地域別、タイプ別、用途別内訳データGlobal Tumor Fluid Biopsy Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application QYResearch社の調査レポート「腫瘍流体生検」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の腫瘍液生検市場は、2023年から2029年の間に年平均成長率%で... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーQYResearch社の調査レポート「腫瘍流体生検」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の腫瘍液生検市場は、2023年から2029年の間に年平均成長率%で、2022年の百万米ドルから増加し、2029年には百万米ドルに達すると予測されている。病院と第三者機関からの需要が業界の主な促進要因である。世界のがん治療薬への支出は、継続的な技術革新により、2021年には1850億ドルに達し、2026年には3000億ドルを超えると予想される。支出の伸びは、新製品やブランド薬の売上急増、医薬品の市場独占権の喪失、バイオシミラーの影響といった複合的な要因によってもたらされる。米国は依然として世界最大のがん治療薬市場であり、これに欧州の主要国が続く。新治療法の加速的普及と価格下落の複合効果により、2021年の中国のがん治療薬への支出は、他の新興市場の合計を上回るとみられる。 レポートの範囲 本レポートは、過去の分析（2018-2022年）と予測計算（2023-2029年）に基づき、読者が世界の腫瘍流体生検市場を多角的に包括的に理解し、読者の戦略と意思決定に十分な支援を提供することを目的としています。 レポート掲載企業、タイプ、用途、地域 企業別 エグザクト・サイエンス セルマックス・ライフ バーニングロック・バイオテック ベリージェノミクス株式会社 ハプロックス・バイオテクノロジー ニューホライズンヘルス ジェネトロンヘルス アモイ・ダイアグノスティックス 広州ウォンドフォバイオテック YZYバイオファーマ ジェノプロレア タイプ別セグメント CTDNA検出 CTC検出 その他 アプリケーション別 病院 第三者機関 その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア ラテンアメリカ メキシコ ブラジル 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 本レポートの各章では、読者が腫瘍流体生検市場をさらに理解するための詳細情報を提供しています： 第1章：歴史と予測期間（2018-2023年、2024-2029年）における世界と地域の市場規模とCAGR。 第2章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品タイプと各タイプの収益分析。 第3章：2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途と各用途の収益分析。 第4章：企業競争状況、製品名企業の競争状況、収益、市場シェアとランキング、最新の開発計画、合併、買収情報などの詳細分析。 第5章：企業概要、企業の基本情報、腫瘍流体生検の紹介などをカバー。各企業の売上高とグロス・マージン、最近の発展もこの部分に含まれる。 第6章から第10章：北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカの国別レベル分析（収益別 第11章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク。 第12章：包括的調査に基づく腫瘍流体生検市場に関するQYResearch社の結論 第13章：QYResearch社が採用した方法論とデータソース。 目次1 Market Overview of Tumor Fluid Biopsy1.1 Tumor Fluid Biopsy Market Overview 1.1.1 Tumor Fluid Biopsy Product Scope 1.1.2 Tumor Fluid Biopsy Market Status and Outlook 1.2 Global Tumor Fluid Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029 1.3 Global Tumor Fluid Biopsy Market Size by Region (2018-2029) 1.4 Global Tumor Fluid Biopsy Historic Market Size by Region (2018-2023) 1.5 Global Tumor Fluid Biopsy Market Size Forecast by Region (2024-2029) 1.6 Key Regions, Tumor Fluid Biopsy Market Size (2018-2029) 1.6.1 North America Tumor Fluid Biopsy Market Size (2018-2029) 1.6.2 Europe Tumor Fluid Biopsy Market Size (2018-2029) 1.6.3 Asia-Pacific Tumor Fluid Biopsy Market Size (2018-2029) 1.6.4 Latin America Tumor Fluid Biopsy Market Size (2018-2029) 1.6.5 Middle East & Africa Tumor Fluid Biopsy Market Size (2018-2029) 2 Tumor Fluid Biopsy Market by Type 2.1 Introduction 2.1.1 CTDNA Detection 2.1.2 CTC Detection 2.1.3 Other 2.2 Global Tumor Fluid Biopsy Market Size by Type: 2018 VS 2022 VS 2029 2.2.1 Global Tumor Fluid Biopsy Historic Market Size by Type (2018-2023) 2.2.2 Global Tumor Fluid Biopsy Forecasted Market Size by Type (2024-2029) 2.3 Key Regions Market Size by Type 2.3.1 North America Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.2 Europe Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.3 Asia-Pacific Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.4 Latin America Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.5 Middle East and Africa Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 3 Tumor Fluid Biopsy Market Overview by Application 3.1 Introduction 3.1.1 Hospital 3.1.2 Third Party Organization 3.1.3 Other 3.2 Global Tumor Fluid Biopsy Market Size by Application: 2018 VS 2022 VS 2029 3.2.1 Global Tumor Fluid Biopsy Historic Market Size by Application (2018-2023) 3.2.2 Global Tumor Fluid Biopsy Forecasted Market Size by Application (2024-2029) 3.3 Key Regions Market Size by Application 3.3.1 North America Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.2 Europe Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.3 Asia-Pacific Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.4 Latin America Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.5 Middle East and Africa Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 4 Tumor Fluid Biopsy Competition Analysis by Players 4.1 Global Tumor Fluid Biopsy Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Fluid Biopsy as of 2022) 4.3 Date of Key Players Enter into Tumor Fluid Biopsy Market 4.4 Global Top Players Tumor Fluid Biopsy Headquarters and Area Served 4.5 Key Players Tumor Fluid Biopsy Product Solution and Service 4.6 Competitive Status 4.6.1 Tumor Fluid Biopsy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles 5.1 Exact Science 5.1.1 Exact Science Profile 5.1.2 Exact Science Main Business 5.1.3 Exact Science Tumor Fluid Biopsy Products, Services and Solutions 5.1.4 Exact Science Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.1.5 Exact Science Recent Developments 5.2 Cellmax Life 5.2.1 Cellmax Life Profile 5.2.2 Cellmax Life Main Business 5.2.3 Cellmax Life Tumor Fluid Biopsy Products, Services and Solutions 5.2.4 Cellmax Life Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.2.5 Cellmax Life Recent Developments 5.3 Burning Rock Biotech 5.3.1 Burning Rock Biotech Profile 5.3.2 Burning Rock Biotech Main Business 5.3.3 Burning Rock Biotech Tumor Fluid Biopsy Products, Services and Solutions 5.3.4 Burning Rock Biotech Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.3.5 Berry Genomics Co Recent Developments 5.4 Berry Genomics Co 5.4.1 Berry Genomics Co Profile 5.4.2 Berry Genomics Co Main Business 5.4.3 Berry Genomics Co Tumor Fluid Biopsy Products, Services and Solutions 5.4.4 Berry Genomics Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.4.5 Berry Genomics Co Recent Developments 5.5 HaploX Biotechnology Co 5.5.1 HaploX Biotechnology Co Profile 5.5.2 HaploX Biotechnology Co Main Business 5.5.3 HaploX Biotechnology Co Tumor Fluid Biopsy Products, Services and Solutions 5.5.4 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.5.5 HaploX Biotechnology Co Recent Developments 5.6 New Horizon Health Limited 5.6.1 New Horizon Health Limited Profile 5.6.2 New Horizon Health Limited Main Business 5.6.3 New Horizon Health Limited Tumor Fluid Biopsy Products, Services and Solutions 5.6.4 New Horizon Health Limited Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.6.5 New Horizon Health Limited Recent Developments 5.7 Genetronhealth 5.7.1 Genetronhealth Profile 5.7.2 Genetronhealth Main Business 5.7.3 Genetronhealth Tumor Fluid Biopsy Products, Services and Solutions 5.7.4 Genetronhealth Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.7.5 Genetronhealth Recent Developments 5.8 Amoy Diagnostics Co 5.8.1 Amoy Diagnostics Co Profile 5.8.2 Amoy Diagnostics Co Main Business 5.8.3 Amoy Diagnostics Co Tumor Fluid Biopsy Products, Services and Solutions 5.8.4 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.8.5 Amoy Diagnostics Co Recent Developments 5.9 Guangzhou Wondfo Biotech 5.9.1 Guangzhou Wondfo Biotech Profile 5.9.2 Guangzhou Wondfo Biotech Main Business 5.9.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Products, Services and Solutions 5.9.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.9.5 Guangzhou Wondfo Biotech Recent Developments 5.10 YZY Biopharma 5.10.1 YZY Biopharma Profile 5.10.2 YZY Biopharma Main Business 5.10.3 YZY Biopharma Tumor Fluid Biopsy Products, Services and Solutions 5.10.4 YZY Biopharma Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.10.5 YZY Biopharma Recent Developments 5.11 GenoploRare 5.11.1 GenoploRare Profile 5.11.2 GenoploRare Main Business 5.11.3 GenoploRare Tumor Fluid Biopsy Products, Services and Solutions 5.11.4 GenoploRare Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.11.5 GenoploRare Recent Developments 6 North America 6.1 North America Tumor Fluid Biopsy Market Size by Country (2018-2029) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Tumor Fluid Biopsy Market Size by Country (2018-2029) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic Countries 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Tumor Fluid Biopsy Market Size by Region (2018-2029) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Tumor Fluid Biopsy Market Size by Country (2018-2029) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2018-2029) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Tumor Fluid Biopsy Market Dynamics 11.1 Tumor Fluid Biopsy Industry Trends 11.2 Tumor Fluid Biopsy Market Drivers 11.3 Tumor Fluid Biopsy Market Challenges 11.4 Tumor Fluid Biopsy Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List
SummaryTumor Fluid Biopsy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tumor Fluid Biopsy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Third Party Organization are the major drivers for the industry. Table of Contents1 Market Overview of Tumor Fluid Biopsy1.1 Tumor Fluid Biopsy Market Overview 1.1.1 Tumor Fluid Biopsy Product Scope 1.1.2 Tumor Fluid Biopsy Market Status and Outlook 1.2 Global Tumor Fluid Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029 1.3 Global Tumor Fluid Biopsy Market Size by Region (2018-2029) 1.4 Global Tumor Fluid Biopsy Historic Market Size by Region (2018-2023) 1.5 Global Tumor Fluid Biopsy Market Size Forecast by Region (2024-2029) 1.6 Key Regions, Tumor Fluid Biopsy Market Size (2018-2029) 1.6.1 North America Tumor Fluid Biopsy Market Size (2018-2029) 1.6.2 Europe Tumor Fluid Biopsy Market Size (2018-2029) 1.6.3 Asia-Pacific Tumor Fluid Biopsy Market Size (2018-2029) 1.6.4 Latin America Tumor Fluid Biopsy Market Size (2018-2029) 1.6.5 Middle East & Africa Tumor Fluid Biopsy Market Size (2018-2029) 2 Tumor Fluid Biopsy Market by Type 2.1 Introduction 2.1.1 CTDNA Detection 2.1.2 CTC Detection 2.1.3 Other 2.2 Global Tumor Fluid Biopsy Market Size by Type: 2018 VS 2022 VS 2029 2.2.1 Global Tumor Fluid Biopsy Historic Market Size by Type (2018-2023) 2.2.2 Global Tumor Fluid Biopsy Forecasted Market Size by Type (2024-2029) 2.3 Key Regions Market Size by Type 2.3.1 North America Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.2 Europe Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.3 Asia-Pacific Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.4 Latin America Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 2.3.5 Middle East and Africa Tumor Fluid Biopsy Revenue Breakdown by Type (2018-2029) 3 Tumor Fluid Biopsy Market Overview by Application 3.1 Introduction 3.1.1 Hospital 3.1.2 Third Party Organization 3.1.3 Other 3.2 Global Tumor Fluid Biopsy Market Size by Application: 2018 VS 2022 VS 2029 3.2.1 Global Tumor Fluid Biopsy Historic Market Size by Application (2018-2023) 3.2.2 Global Tumor Fluid Biopsy Forecasted Market Size by Application (2024-2029) 3.3 Key Regions Market Size by Application 3.3.1 North America Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.2 Europe Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.3 Asia-Pacific Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.4 Latin America Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 3.3.5 Middle East and Africa Tumor Fluid Biopsy Revenue Breakdown by Application (2018-2029) 4 Tumor Fluid Biopsy Competition Analysis by Players 4.1 Global Tumor Fluid Biopsy Market Size by Players (2018-2023) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Fluid Biopsy as of 2022) 4.3 Date of Key Players Enter into Tumor Fluid Biopsy Market 4.4 Global Top Players Tumor Fluid Biopsy Headquarters and Area Served 4.5 Key Players Tumor Fluid Biopsy Product Solution and Service 4.6 Competitive Status 4.6.1 Tumor Fluid Biopsy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles 5.1 Exact Science 5.1.1 Exact Science Profile 5.1.2 Exact Science Main Business 5.1.3 Exact Science Tumor Fluid Biopsy Products, Services and Solutions 5.1.4 Exact Science Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.1.5 Exact Science Recent Developments 5.2 Cellmax Life 5.2.1 Cellmax Life Profile 5.2.2 Cellmax Life Main Business 5.2.3 Cellmax Life Tumor Fluid Biopsy Products, Services and Solutions 5.2.4 Cellmax Life Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.2.5 Cellmax Life Recent Developments 5.3 Burning Rock Biotech 5.3.1 Burning Rock Biotech Profile 5.3.2 Burning Rock Biotech Main Business 5.3.3 Burning Rock Biotech Tumor Fluid Biopsy Products, Services and Solutions 5.3.4 Burning Rock Biotech Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.3.5 Berry Genomics Co Recent Developments 5.4 Berry Genomics Co 5.4.1 Berry Genomics Co Profile 5.4.2 Berry Genomics Co Main Business 5.4.3 Berry Genomics Co Tumor Fluid Biopsy Products, Services and Solutions 5.4.4 Berry Genomics Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.4.5 Berry Genomics Co Recent Developments 5.5 HaploX Biotechnology Co 5.5.1 HaploX Biotechnology Co Profile 5.5.2 HaploX Biotechnology Co Main Business 5.5.3 HaploX Biotechnology Co Tumor Fluid Biopsy Products, Services and Solutions 5.5.4 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.5.5 HaploX Biotechnology Co Recent Developments 5.6 New Horizon Health Limited 5.6.1 New Horizon Health Limited Profile 5.6.2 New Horizon Health Limited Main Business 5.6.3 New Horizon Health Limited Tumor Fluid Biopsy Products, Services and Solutions 5.6.4 New Horizon Health Limited Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.6.5 New Horizon Health Limited Recent Developments 5.7 Genetronhealth 5.7.1 Genetronhealth Profile 5.7.2 Genetronhealth Main Business 5.7.3 Genetronhealth Tumor Fluid Biopsy Products, Services and Solutions 5.7.4 Genetronhealth Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.7.5 Genetronhealth Recent Developments 5.8 Amoy Diagnostics Co 5.8.1 Amoy Diagnostics Co Profile 5.8.2 Amoy Diagnostics Co Main Business 5.8.3 Amoy Diagnostics Co Tumor Fluid Biopsy Products, Services and Solutions 5.8.4 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.8.5 Amoy Diagnostics Co Recent Developments 5.9 Guangzhou Wondfo Biotech 5.9.1 Guangzhou Wondfo Biotech Profile 5.9.2 Guangzhou Wondfo Biotech Main Business 5.9.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Products, Services and Solutions 5.9.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.9.5 Guangzhou Wondfo Biotech Recent Developments 5.10 YZY Biopharma 5.10.1 YZY Biopharma Profile 5.10.2 YZY Biopharma Main Business 5.10.3 YZY Biopharma Tumor Fluid Biopsy Products, Services and Solutions 5.10.4 YZY Biopharma Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.10.5 YZY Biopharma Recent Developments 5.11 GenoploRare 5.11.1 GenoploRare Profile 5.11.2 GenoploRare Main Business 5.11.3 GenoploRare Tumor Fluid Biopsy Products, Services and Solutions 5.11.4 GenoploRare Tumor Fluid Biopsy Revenue (US$ Million) & (2018-2023) 5.11.5 GenoploRare Recent Developments 6 North America 6.1 North America Tumor Fluid Biopsy Market Size by Country (2018-2029) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Tumor Fluid Biopsy Market Size by Country (2018-2029) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic Countries 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Tumor Fluid Biopsy Market Size by Region (2018-2029) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Tumor Fluid Biopsy Market Size by Country (2018-2029) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2018-2029) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Tumor Fluid Biopsy Market Dynamics 11.1 Tumor Fluid Biopsy Industry Trends 11.2 Tumor Fluid Biopsy Market Drivers 11.3 Tumor Fluid Biopsy Market Challenges 11.4 Tumor Fluid Biopsy Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（breakdown data）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |
